11-111306577-T-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001271458.2(POU2AF3):āc.341T>Gā(p.Phe114Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00143 in 1,551,732 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001271458.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POU2AF3 | NM_001271458.2 | c.341T>G | p.Phe114Cys | missense_variant | 4/5 | ENST00000610738.6 | NP_001258387.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POU2AF3 | ENST00000610738.6 | c.341T>G | p.Phe114Cys | missense_variant | 4/5 | 1 | NM_001271458.2 | ENSP00000484135.1 |
Frequencies
GnomAD3 genomes AF: 0.000835 AC: 127AN: 152166Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000739 AC: 116AN: 156964Hom.: 0 AF XY: 0.000722 AC XY: 60AN XY: 83066
GnomAD4 exome AF: 0.00150 AC: 2098AN: 1399448Hom.: 1 Cov.: 31 AF XY: 0.00151 AC XY: 1039AN XY: 690230
GnomAD4 genome AF: 0.000834 AC: 127AN: 152284Hom.: 1 Cov.: 32 AF XY: 0.000846 AC XY: 63AN XY: 74468
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 28, 2022 | The c.50T>G (p.F17C) alteration is located in exon 4 (coding exon 1) of the COLCA2 gene. This alteration results from a T to G substitution at nucleotide position 50, causing the phenylalanine (F) at amino acid position 17 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at